Description

BSE lists 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective March 6, 2026.

Summary

BSE has notified trading members that 43,04,000 new equity shares of Dr Lalchandani Labs Limited (Scrip Code: 541299) are listed and permitted to trade on the Exchange with effect from Friday, March 6, 2026. The shares were issued at par on a rights basis.

Key Points

  • 43,04,000 equity shares of Rs. 10/- each issued at par on rights basis
  • ISIN: INE871Z01013
  • Distribution Numbers: 4333069 to 8637068
  • Shares rank pari-passu with existing equity shares of the company
  • Effective trading date: March 6, 2026

Regulatory Changes

No regulatory changes. This is a routine listing notification for newly issued securities.

Compliance Requirements

Trading members are informed to update their records and systems to reflect the new securities available for trading from March 6, 2026.

Important Dates

  • Date of Allotment: February 28, 2026
  • Effective Trading Date: March 6, 2026 (Friday)

Impact Assessment

Limited market impact. The listing adds 43,04,000 new equity shares to the existing float of Dr Lalchandani Labs Limited. As a rights issue at par, existing shareholders have already been given the opportunity to subscribe. The shares rank pari-passu with existing shares, meaning no dilution of rights for existing shareholders beyond the rights issue itself.

Impact Justification

Routine listing of new equity shares issued on rights basis for a single company; no regulatory changes or broad market impact.